Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 24.82B | 23.57B | 24.92B | 24.44B | 19.65B | 17.60B |
Gross Profit | 5.14B | 5.99B | 3.30B | 2.14B | 2.75B | 3.27B |
EBITDA | 6.39B | 6.97B | 4.22B | 2.92B | 3.81B | 4.31B |
Net Income | 3.01B | 3.75B | 1.62B | -160.00M | -205.00M | 589.00M |
Balance Sheet | ||||||
Total Assets | 53.04B | 52.93B | 50.76B | 46.91B | 48.09B | 48.09B |
Cash, Cash Equivalents and Short-Term Investments | 2.06B | 3.02B | 368.00M | 422.00M | 504.00M | 226.00M |
Total Debt | 8.31B | 8.41B | 9.26B | 5.77B | 8.20B | 7.21B |
Total Liabilities | 39.23B | 39.39B | 39.47B | 35.54B | 36.47B | 33.42B |
Stockholders Equity | 13.45B | 13.17B | 10.93B | 11.02B | 11.22B | 12.40B |
Cash Flow | ||||||
Free Cash Flow | -2.40B | -5.03B | -7.72B | -4.04B | -2.67B | -1.16B |
Operating Cash Flow | 456.00M | -2.46B | -5.30B | -2.35B | -1.34B | 584.00M |
Investing Cash Flow | 3.02B | 7.43B | 3.03B | 3.10B | 3.28B | 1.96B |
Financing Cash Flow | -1.80B | -2.29B | 2.20B | -799.00M | -1.70B | -2.66B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | 71.59B | 33.34 | 47.74% | 0.42% | 46.90% | 388.66% | |
71 Outperform | 94.15B | 19.68 | 9.50% | 3.47% | 4.07% | 9.94% | |
68 Neutral | 146.37B | 24.67 | 11.65% | 3.12% | 18.80% | -6.73% | |
65 Neutral | $103.38B | 33.68 | 24.20% | 0.46% | 13.41% | 27.49% | |
61 Neutral | 5.63B | 41.59 | 4.11% | 6.51% | -0.27% | -16.25% | |
48 Neutral | 6.06B | -4.59 | -1174.68% | 4.37% | 12.46% | -388.89% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% |